Cargando…
Adoptive Immunotherapy and High-Risk Myeloma
SIMPLE SUMMARY: Multiple myeloma is a cancer of the bone marrow which accounts for approximately 1.8% of all cancer diagnoses worldwide. The clinical outcomes for patients with multiple myeloma have significantly improved in the most recent decade, resulting in better quality of life and prolonged s...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177276/ https://www.ncbi.nlm.nih.gov/pubmed/37174099 http://dx.doi.org/10.3390/cancers15092633 |